rhenium has been researched along with Peritoneal Carcinomatosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CH; Chang, TJ; Chang, YJ; Chen, LC; Ho, CL; Hsu, CW; Lan, KL; Lee, TW; Lee, WC; Liu, IH; Ni, HC; Ting, G; Tsai, CC; Wu, YH | 1 |
Fallone, BG; McQuarrie, SA; Middleton, JW; Syme, AM | 1 |
Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Koppe, MJ; Oyen, WJ; Soede, AC; Verhofstad, AA | 1 |
Izumo, M; Kinuya, S; Michigishi, T; Mori, H; Obata, T; Shiba, K; Shuke, N; Sorita, T; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
4 other study(ies) available for rhenium and Peritoneal Carcinomatosis
Article | Year |
---|---|
Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Topics: Animals; Ascites; Fluorouracil; Injections, Intravenous; Kaplan-Meier Estimate; Liposomes; Male; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2011 |
Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases.
Topics: Biophysical Phenomena; Biophysics; CA-125 Antigen; Computer Simulation; Female; Humans; Injections, Intraperitoneal; Liposomes; Models, Biological; Ovarian Neoplasms; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Rhenium | 2003 |
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Iodine Radioisotopes; Lutetium; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes | 2004 |
Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.
Topics: Animals; Antibodies, Monoclonal; Colonic Neoplasms; Disease Models, Animal; Injections, Intraperitoneal; Iodine Radioisotopes; Maximum Tolerated Dose; Mice; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution | 2005 |